The terms of Medtronic's unusual $43 billion acquisition of Covidien means that all MDT shareholders are subject to paying a capital gains tax, including executives and board members.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/VdxJb0
Cap comentari:
Publica un comentari a l'entrada